Articles by Ben Comer - Pharmaceutical Executive

ADVERTISEMENT

Articles by Ben Comer

Pharm Exec's Annual Industry Outlook 2014

Jan 21, 2014

For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive — muddling through is so yesterday.

Brand vs. Generic: Physicians Weigh In

Dec 1, 2013

Why do some doctors prescribe more generic drugs than others?

2014 Pipeline Report: The Sprint to Value

Nov 1, 2013

Across a constellation of categories, bright new drugs are moving into position. The pharma model may have changed, but companies are keeping their blockbusters.

Top Medical Innovations for 2014

Nov 1, 2013

At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability.

Using Data to Influence Behavior and Predict Outcomes

Oct 1, 2013

Predictive analysis has been used to great effect in the finance, tech, retail, and telecoms industries. Can it also improve decision-making and health outcomes in life sciences?

Field Force Evolution: Adapting to a New Ecosystem

Oct 1, 2013

Environmental changes on all sides of professional sale are forcing biopharmaceutical companies to select for new traits in the makeup of the field force function.

Share of Screen: Prioritizing Electronic Health Records

Sep 1, 2013

Are electronic health records a viable channel for engagement? Ben Comer reports.

Take a Chill Pill

Aug 1, 2013

In the spirit of lawn chair cogitation and hammock-spun reverie, Pharm Exec invites you to submit your own verses—pharma-related, of course—to be published on our website in late August.

What is a Journal Reprint Worth?

Jul 1, 2013

Pharma and physicians worry about getting sunburned by the Sunshine Act.

ADVERTISEMENT

Click here